Individuals who are identified as having a substance use disorder and a co-occurring mental health disorder are welcomed at KDC. Key Development has a physician on staff who is Board Certified in Addiction Medicine. Psychiatric evaluations and medication monitoring are provided for those individuals identified as having a co-occurring disorder and/or need Medication Assisted Treatment (MAT).
Goal: The goal of psychiatric assessment is to establish a diagnosis and formulation of the client’s difficulties and to make a plan for their care and treatment.
Psychiatric Evaluation:is an assessment that is designed to diagnose emotional, behavioral and substance use disorders. This initial evaluation explores many aspects that include medical, family, social and environmental influences, academic/work concerns and emotional and cognitive strengths and weaknesses. A typical psychiatric evaluation will be 60 minutes.
Medication review: is an assessment of the client’s health conditions while on medication. It is used to analyze the effectiveness of the medication and determine whether the medications are working. This time is also used to develop new and improved care plans and assist the client in attaining the best results from their medications. A typical medication review will last approximately 30 minutes.
Medication Assisted Treatment: Key Development Center is able to provide medication assisted treatment (MAT) for substance use disorders. MAT involves the use of substances approved by the FDA to assist individuals who are suffering from alcohol or opioid addiction. MAT is intended to prevent the use of harmful substances by administering medication that blocks cravings or act as a substitute. KDC has been providing Suboxone treatment for the last six years and in July 2018 successfully implemented a Vivitrol Program. Those individuals who request Vivitrol treatment must attend a mandatory orientation at KDC.